Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methods for optimizing antiviral combination therapies.

Niko Beerenwinkel1, Thomas Lengauer, Martin Däumer

  • 1Max Planck Institute for Informatics, Stuhlsatzenhausweg 85, 66123 Saarbrücken, Germany. beerenwinkel@mpi-sb.mpg.de

Bioinformatics (Oxford, England)
|July 12, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-derived glioblastoma cultures preserve respiration phenotypes during ex vivo maintenance and show sex-associated differences in migration.

Acta neuropathologica communications·2026
Same author

Real-world walking speed as a digital biomarker and outcome measure for clinical trials-a systematic review, regulatory status and future directions.

Frontiers in digital health·2026
Same author

Multiplets in scRNA-seq data: Extent of the problem and efficacy of methods for removal.

PloS one·2025
Same author

High-resolution spatial transcriptomics uncover epidermal-dermal divergences in Merkel cell carcinoma: spatial context reshapes the gene expression landscape.

Oncogene·2025
Same author

Establishment of an Advanced In Vitro Model for Pseudoexfoliation Syndrome and Glaucoma.

Investigative ophthalmology & visual science·2025
Same author

Bath: a Bayesian approach to analyze epigenetic transitions reveals a dual role of H3K27me3 in chondrogenesis.

Epigenetics & chromatin·2025
Same journal

MCFST: Spatial domain identification method based on multi-view graph convolutional network and graph fusion network.

Bioinformatics (Oxford, England)·2026
Same journal

SpaBiT: Enhancing Spatial Transcriptomics Resolution via Bidirectional Attention Transformers.

Bioinformatics (Oxford, England)·2026
Same journal

EDEL: Enhancing Dense Retrievers for Curation of Biomedical Knowledge Bases.

Bioinformatics (Oxford, England)·2026
Same journal

Informative Relational Learning for Adverse Reaction Prediction with Enhanced Generalization to Novel Drugs.

Bioinformatics (Oxford, England)·2026
Same journal

An interpretable deep learning framework uncovers features governing CRISPR-Cas9 genome-editing efficiency.

Bioinformatics (Oxford, England)·2026
Same journal

3DICE: Interpretable 3D Cross-Modal Learning for Drug-Target Interaction Prediction and Large-Scale Drug Discovery.

Bioinformatics (Oxford, England)·2026
See all related articles

A new scoring function predicts antiviral drug combination activity against HIV by analyzing genetic mutations. This approach aids in selecting effective treatments after therapy failure, improving patient outcomes.

Area of Science:

  • Virology
  • Computational Biology
  • Pharmacology

Background:

  • Antiretroviral combination therapies for HIV have limitations.
  • Drug-resistant viral variants contribute to treatment failure.
  • Developing new effective drug combinations after failure is challenging.

Purpose of the Study:

  • To develop a predictive scoring function for antiviral drug combination activity against HIV.
  • To assess the function's ability to predict therapeutic outcomes in HIV patients.

Main Methods:

  • Developed a scoring function using antiviral agents and viral DNA sequences.
  • Predicted individual drug resistance from genotypes.
  • Integrated probabilistic modeling of resistance for drug combinations.

Related Experiment Videos

  • Estimated activity on nearby viral mutants by searching the mutational neighborhood.

    • Main Results:

    • The scoring function effectively estimates drug combination activity.
    • The scoring scheme was predictive of therapeutic outcomes in a clinical dataset.
    • Optimal search depth for the scoring function was determined.

    Conclusions:

    • The developed scoring function is a valuable tool for predicting HIV drug combination efficacy.
    • This method can guide the selection of effective treatments, especially after therapy failure.
    • Further applications of the activity score in HIV management are discussed.